
BIRMINGHAM, UK – The Birmingham Assay Office has announced that Doug Henry will be stepping down as Assay Master and Chief Executive Officer, with Roxanne Guest appointed as his successor, effective 1 April 2026.
Doug Henry has led the Birmingham Assay Office through a period of significant change, providing strong leadership and strategic direction, a statement said.
Roxanne Guest, currently Deputy Chief Executive, will assume the role of Assay Master and Chief Executive Officer.
Roxanne brings operational experience within the Assay Office,
having played a key role in delivering service performance, operational improvements, and business transformation initiatives.
















